Search

everythinglearnresearchcommunity

for

Search:↓

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

New genes and pathways are important for testosterone production and male sexual development.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

Safflower extract helps protect hair follicle cells from damage caused by chemotherapy.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Finasteride and minoxidil together promote hair growth better than either alone.

Alcohol in teen years leads to more adult drinking, finasteride doesn't help.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

A woman was allergic to quinine in her anti-hair loss lotion.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.